Lundbeck names new CEO

DEERFIELD - H. Lundbeck, Denmark, announced that it named Sean Nolan chief executive officer of its U.S. business, Lundbeck Inc., succeeding Jeffrey S. Aronin.

Nolan has been with the company for more than five years in a variety of roles, most recently as chief commercial officer.

Following Lundbeck's acquisition of Ovation Pharmaceuticals earlier this year, he led the Lundbeck Inc. integration team charged with the successful and timely integration of Ovation Pharmaceuticals into Lundbeck.

Before joining Ovation, he worked in the Pharmaceutical Products Division of Abbott Laboratories for 13 years.